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ABSTRACT 
 
 
 
 
Cervical cancer has one of the highest death recorded percentages among 
women in the world especially in less developed countries.  Moreover, the presence 
of cancer stem cells in cervical cancer tumours is believed to cause resistance to 
conventional therapies.  Previous studies have shown that C. nutans extracts possess 
antioxidant and anti-proliferative effects towards several cervical cancer cell lines 
including HeLa cells.  This study is focused at examining the anticancer effects of 
ethanolic C. nutans leave extract on cervical cancer cell viability, proliferation and 
its ability to induce apoptosis in cervical cancer cells.  In order to achieve these 
objectives, the MTS, CyQuant and active caspase 3/7 assays as well as 
immunofluorescence microscopy analysis were conducted respectively on Hela cells 
which represent an invasive form of cervical cancer.  Treatment of C. nutans leave 
extract at concentrations of 0-50 µg/mL showed a significant reduction in cell 
viability and proliferation in a dose dependent manner on the Hela cells.  An IC50 of 
40 μg/mL and 20 μg/mL C. nutans were observed respectively in inducing reduction 
in cell viability and proliferation.  Furthermore, Hela cells treated with C. nutans 
resulted in a reduced expression level of CD133 cervical cancer stem cell maker 
compared to the untreated cells.  A further reduction in cell proliferation compared to 
cell viability in Hela cells and reduced CD133 expression may suggest that C. nutans 
may specifically target cervical cancer stem cells.  Additionally, an increased 
caspase-3/7 activity in Hela cells treated with C. nutans indicated that the plant 
extract induced apoptosis.  Apoptosis was also demonstrated through change in Hela 
cell morphology and formation of apoptotic bodies upon C. nutans.  Findings of this 
study suggest that C. nutans is a potential anticancer agent which can be used in 
adjuvant chemotherapy treatment of cervical cancer. 
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ABSTRAK 
 
 
 
 
Kanser servik merupakan salah satu kanser yang mencatatkan peratusan 
kadar kematian yang tinggi dalam kalangan wanita terutama di negara yang kurang 
membangun.  Selain itu, kehadiran stem sel kanser dalam ketumbuhan kanser servik, 
dipercayai telah menjadi halangan kepada terapi konvensional.  Kajian terdahulu 
telah menunjukkan bahawa ekstrak tumbuhan ini mempunyai kesan antioksida dan 
anti-proliferatif terhadap sel kanser servik termasuk sel HeLa.  Kajian ini telah 
menyasarkan untuk mengkaji kesan antikanser ekstrak etanol C. nutans seperti kadar 
sel hidup dan proliferatif disamping kemampuan untuk mencetuskan apoptosis 
terhadap sel kanser servik.  Bagi mencapai kesemua objektif kajian ini, kaedah MTS, 
CyQuant, caspase 3/7 yang aktif dan mikroskop immunofluoresen telah dianalisis 
terhadap sel HeLa yang juga mewakili bentuk invasif kepada sel kanser servik.  
Rawatan ekstrak daun C. nutans pada kepekatan antara 0-50 µg/mL telah 
menunjukkan pengurangan sel hidup dan proliferatif yang ketara terhadap sel HeLa.  
IC50 C. nutans pada kepekatan 40 μg/mL dan 20 μg/mL, tiap-tiap satunya telah 
dilihat mencetuskan pengurangan sel hidup dan proliferatif.  Tambahan pula, sel 
HeLa yang dirawat dengan C. nutans telah menunjukkan pengurangan kadar 
pengekspresan CD133 penanda stem sel kanser servik berbanding sel yang tidak 
dirawat.  Hasil kajian ini mencadangkan bahawa C. nutans mampu mensasarkan 
stem sel kanser servik.  Disamping itu, peningkatan aktiviti caspase-3/7 dalam sel 
HeLa yang dirawat dengan C. nutans menunjukkan ekstrak tumbuhan ini mampu 
mencetuskan apoptosis.  Kesan apoptosis juga ditunjukkan melalui morfologi sel 
HeLa dan pembentukan badan apoptotic kesan daripada rawatan C. nutans.  Kajian 
ini telah membuktikan bahawa C. nutans berpotensi untuk menjadi ejen yang 
membantu rawatan kanser servik. 
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 CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1     Background of Study  
 
 
One of the main leading causes of morbidity in the world is cancer with 
reported estimation of 8.2 million deaths and 14 million new cases in 2012 (Ferlay et 
al., 2015).  Additionally, this number is predicted to increase by 70% over the next 
20 years (Stewart et al., 2014).  According to the Global Cancer Statistics in 2012, 
cervical cancer is the third leading cancer that causes deaths in less developed 
countries and number fourth in the worldwide for the most common cause of cancer 
among females (Torre et al., 2015).  It is estimated that about 230, 200 cervical 
cancer cases took place in developing countries (Hun et al., 2015).  In addition, the 
International Agency for Research on Cancer (IARC) has claimed that in 2012 alone, 
a woman was dying every four minutes due to cervical cancer in Asian Pacific 
countries including Malaysia (Farooqui et al., 2013).  In 2010, a summary report by 
WHO/ICO (Institut Catala d’Oncologia) stated that 631 people die among the 2126 
Malaysian women who were diagnosed with cervical cancer annually (Muhamad et 
al., 2015).  All of these facts had proven that cervical cancer is one of the most 
deadly diseases among women. 
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Cervical cancer commonly occurs through abnormal cell growth lining the 
cervix area (Sharma et al., 2017).  In general, the cervix area is considered as the 
lower part of the uterus up to the end of the vagina.  There are several causes of 
cervical cancer including human papillomavirus (HPV) infection, smoking, having 
sex with many partners and consume of birth control pills (Jemal et al., 2011; Torre 
et al., 2015).  Among them, the most reported cases were caused by the infection of 
HPV with 99% detection in cervical tumour (Hun et al., 2015).  Particularly, HPV 
have several subtypes and there are two oncogenic subtypes that lead to the cervical 
cancers that are HPV types 16 and 18 (Colombo et al., 2012).  Many studies have 
been done to develop vaccines that could prevent from high-risk types of HPV 
infection such as HPV types 16 and 18 (Yeung et al., 2011). 
 
 
Some of the popular treatments used to treat cervical cancer are surgery, 
radiation, chemotherapy and some cases used combination of chemotherapy and 
radiation (Varatharajan et al., 2012).  In addition to surgery and radiation, the used of 
cytotoxic chemotherapeutic drugs to treat cervical cancer also become one of the 
popular method to treat late stage cancer.  Though it becomes one of the main cancer 
treatment methods, the used of conventional chemotherapeutic drugs usually resulted 
to the severe side effects toward patients as well as multidrug resistance 
(Pratheeshkumar et al., 2012; Fong et al., 2016).  Other than conventional 
treatments, alternative treatment by using the combination of conventional 
therapeutic drugs with medicinal plants is very popular lately among modern 
medicinal practitioner.  Moreover, most of the clinically established medicines were 
originally made from natural based product (Ravishankar et al., 2013).  Several 
studies had reported the anticancer effects of medicinal plants toward several cancer 
cells (Fong et al., 2016).  
 
 
At present, there are rapid and extensive studies to develop therapeutic drugs 
that can be used in chemotherapy treatment to treat cervical cancer (Bruni et al., 
2014).  Natural source based therapeutic drug are getting much attention in research 
for its low-toxicity effect toward non-cancerous cells which may reduce the side 
effects of the treatment (Yong et al., 2013).  Thus, most of the recent researches are 
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focusing to discover novel bioactive compound from medicinal plants which are one 
of the main ingredients used in natural-based therapeutic drugs (Fong et al., 2016).  
One of the medical plants that have been identified as an anticancer agent is 
Clinacanthus nutans (C. nutans) (Danmin et al., 2015).  C. nutans is a medicinal 
herb with proven anticancer, antiviral, anti-inflammatory and antioxidant properties 
has become an important plant of research in the recent years (Ruhaiyem et al., 
2015).  Most of the phytochemical constituents extracted and isolated from leaves, 
roots, stems, barks, flowers and bulbs of the plant had demonstrated anticancer 
properties (Fong et al., 2016).  In addition, C. nutans leaf extracts has been proven 
for its bioactive compounds which act as potential antioxidants as well as cytotoxic 
and antimicrobial agents (Sangeetha et al., 2014).  
 
 
Several bioactive components that have been isolated from C. nutans are 
flavonoids, terpenoids, glycoglycerolipids, C-glycosyl flavones and sulphur 
containing glucosides (Ruhaiyem et al., 2015).  Whilst the main compound isolated 
from crude ethanol C. nutans leaf extract is flavonoids which consists of catechin, 
quercetin, kaempferol and luteolin (Ghasemzadeh et al., 2014).  This polyphenolic 
compounds have been reported possessed a wide spectrum of pharmacological 
effects such as anti-cancer activities.  Previous studies revealed that this plant 
secondary metabolite mediated in the cancer induction and progression through 
regulation of various enzymes and receptors during signal transduction pathways 
associated to apoptosis, differentiation, inflammation, proliferation, metastasis and 
angiogenesis (Ravishankar et al., 2013).   
 
 
Some previous and recent studies have been done separately to determine C. 
nutans cytotoxicity and anti-proliferative effects toward several cancer cells (Yong et 
al., 2013; Fong et al., 2016).  Cell proliferation and apoptosis can be considered as 
one of the main mechanisms in cancer prevention (Fazil et al., 2016).  Apoptosis or 
cell cycle arrest induction might be one of the mechanisms for HeLa cell growth 
inhibition caused by C. nutans.  Unfortunately, the complete mechanism of action of 
C. nutans as an anticancer agent toward HeLa cells has not yet studied.  Therefore, 
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this study approaches to identify the possible mechanism of action of C. nutans 
extract in cervical cancer cells which may aid in the treatment of cervical cancer. 
 
 
Three main assays were used in this study to determine the cytotoxic effect, 
proliferative activity and mechanism of C. nutans toward HeLa cells.  The first assay 
used was metabolic-based assay where the number of viable cells detected is based 
on the reduction of MTS tetrazolium salt into formazan product (Wang et al., 2010).  
Next, the second assay used was DNA-based assay where the proliferative activity of 
HeLa cells was demonstrated by the binding of fluorescent dye to the nucleic acid of 
the cells.  This cellular DNA-based method has been proven to be slightly more 
sensitive than metabolic activity assay as the number of viable cells is determined by 
the highly regulated cellular DNA in the cells (Jones et al., 2001; Fazil et al., 2016).  
Cellular DNA is highly regulated in living cells and this will allow the binding of 
fluorescent dye which then can be detected through fluorescent microplate reader 
with suitable excitation wavelength (Wang et al., 2010).  The last assay used in this 
study was apoptotic assay.  This assay was done to determine the mechanism of C. 
nutans toward HeLa cells.  Only the half maximal inhibitory concentration (IC50) 
was used for this assay.  Overall, this study presented the cytotoxicity and anti-
proliferative effect of C. nutans together with its anticancer mechanism toward HeLa 
cells.  
 
 
 
 
1.2   Problem Statement 
 
 
The survival rate of cervical cancer for less developed regions such as Eastern 
and Middle Africa still at the lowest percentage compare to the more developed 
regions (Hun et al., 2015).  Additionally, cervical cancer related vaccine such as 
cervarix is too costly for low and middle income patients to afford (Fagot et al., 
2011; Kemp et al., 2011; Siegel et al., 2012).  Therefore, in order to reduce drug cost 
for this cancer treatment, many local traditional medicinal plants with potential 
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anticancer properties are being identified and studied.  Despite all available 
conventional treatments used to treat cervical cancer, detrimental effects toward 
patients due to acquired resistance to drugs or treatments as well as unspecific 
cytotoxicity inducing drugs have urged medical practitioner to shift their focus 
towards alternative treatment by using non-toxic plant-derived therapeutic drugs 
(Filipa Brito et al., 2015; Alam et al., 2016).  C. nutans has been known as a 
traditional medicinal herb that used to treat various kinds of diseases including 
cancer (Yong et al., 2013).  Its antiviral, antioxidant and anti-proliferative effects has 
been proved and mainly caused by the effect of its bioactive compounds such as 
flavonoids and phytosterols (Sak, 2014; Ghasemzadeh et al., 2014).  Although C. 
nutans has been tested in several cancer cells and types of solvent, but previous 
studies had showed that there was only one type of solvent that have IC50 less than 
20 μg/mL which is the allowed dosed fixed by the National Cancer Institute (NCI) 
for potential anticancer drug.  The cytotoxic effect of this herb towards cervical 
cancer cell line such as HeLa has made it as a potential chemopreventive agent in 
cervical cancer treatment (Yong et al., 2013).  Thus in this current study, we wish to 
see the cytotoxicity effect of C. nutans particularly in ethanolic extract toward HeLa 
cells.  
 
 
 
 
1.3 Objectives of the Study 
 
 
Following are the objectives of this study: 
1) To study the cytotoxic effects of C. nutans crude extract in cervical 
cancer cells. 
2) To investigate the anti-proliferative effects of C. nutans crude extract in 
cervical cancer cells. 
3) To determine the ability of C. nutans crude extract to induce apoptosis in 
cervical cancer cells. 
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1.4 Scope of the Study 
 
 
The scope of this study is to elucidate the anticancer effect of C. nutans 
towards cervical cancer cells by studying its cytotoxic and anti-proliferative effects 
as well as its ability to induced apoptosis.  The first two objectives of this study were 
focused on the identification of the cytotoxic and anti-proliferative effects of C. 
nutans crude extract in HeLa cells line.  Then the apoptotic assay was done by 
comparing C. nutans treated HeLa cells with control (untreated) HeLa cells and 
Taxol treated HeLa cells as positive control.  Overall, this study is aimed at 
evaluating the effectiveness of C. nutans in cervical cancer cells treatment for the 
development of cancer therapeutic drug. 
 
 
 
 
1.5 Significance of the Study 
 
 
The unspecific cytotoxicity and severe side effects caused by conventional 
drugs in chemotherapy treatment of cervical cancer has changed the interest of 
medical practitioner to identify a potential therapeutic agent from natural-based 
source.  Several previous studies proved that natural-based drug has reduced side 
effect and non-toxic to the non-cancerous cells (Yong et al., 2013; Alam et al., 
2016).  This study evaluates the potential of Clinacanthus nutans as an anticancer 
agent in the cancer cervical treatment.  The used of plant-based therapeutic drugs as 
alternative treatment to treat cervical cancer not only cost effective but also cause no 
harm to patients in comparison to the current conventional treatments.  Thus, it is 
important to study for the cytotoxicity of this medicinal plant toward HeLa cervical 
cancer cell line before it can be used in a clinical treatment.  Furthermore, this study 
also identified the mechanism of C. nutans crude extracts toward HeLa cells.  The 
determination of C. nutans anticancer effect will give an insight to medical 
practitioner on how its work to halt the development of HeLa cells in cervical cancer.  
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